Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

Need Help? Chat with us
Kapy Pharmaceutical

Emceft- CV Tablets Supplier

Emceft- CV Tablets
Business Type Supplier, Retailer
Composition of Product Cefuroxime 500 mg + Clavulanate 125 mg
Pack Size 10X10
Pack Type Alu-Alu
Click to view more

Preferred Buyer From

Location Worldwide

Product Details

Therapeutic Classification
Antibiotic
Form
Tablets
Storage
store in a cool, dry place and avoid direct sunlight

Cefuroxime 500mg + Clavulanic acid 125mg Salt Information :

Uses of Cefuroxime 500mg + Clavulanic acid 125mg:
Cefuroxime is a cephalosporin antibiotic. Cefuroxime is used in the treatment of various bacterial infections. Cefuroxime is used in infections of respiratory tract infections like pharyngitis, otitis media, sinusitis, and bronchitis.

Side Effects of Cefuroxime 500mg + Clavulanic acid 125mg:
Large doses can cause cerebral irritation and convulsions; nausea, vomiting, diarrhoea, GI disturbances; erythema multiforme, Stevens-Johnson syndrome, epidermal necrolysis. Potentially Fatal: Anaphylaxis, nephrotoxicity, pseudomembranous colitis.

Drug Interactions of Cefuroxime 500mg + Clavulanic acid 125mg:
Probenecid decreases renal clearance of cefuroxime. Potentially Fatal: Nephrotoxicity with aminoglycosides and furosemide.

Contraindications of Cefuroxime 500mg + Clavulanic acid 125mg:
Hypersensitivity to cephalosporins.

Mechanism of Action of Cefuroxime 500mg + Clavulanic acid 125mg:
Cefuroxime binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. Absorption: Absorbed from the GI tract with peak plasma concentrations after 2-3 hr (oral); may be enhanced by the presence of food. Distribution: Pleural and synovial fluid, sputum, bone and aqueous fluids; CSF (therapeutic concentrations). Crosses the placenta and enters breast milk. Protein-binding: Up to 50%. Metabolism: Rapidly hydrolysed (intestinal mucosa and blood). Excretion: Via the urine by glomerular filtration and renal tubular secretion (as unchanged); via bile (small amounts); 70 min (elimination half-life); prolonged in neonates and renal impairment.

Read More...

Yes! I am interested

Looking for "Emceft- CV Tablets" ?

Explore More Products